[Effects of EGFR gene polymorphisms on efficacy and prognosis in advanced non-small cell lung cancer treated with EGFR-TKIs].

Abstract

An increasing number of patients with advanced non-small cell lung cancer (NSCLC) have been treated with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). However, significant differences in response to EGFR-TKIs have been shown among advanced NSCLC patients. Recently, selection of patients was mainly based on EGFR gene mutation… (More)
DOI: 10.3779/j.issn.1009-3419.2013.03.09

Topics

Cite this paper

@article{Da2013EffectsOE, title={[Effects of EGFR gene polymorphisms on efficacy and prognosis in advanced non-small cell lung cancer treated with EGFR-TKIs].}, author={Liangshan Da and Lin Xu}, journal={Zhongguo fei ai za zhi = Chinese journal of lung cancer}, year={2013}, volume={16 3}, pages={162-5} }